In contrast, TAp73 confers a proliferative advantage to CRC cells, as it transcriptionally activates G6PD and drives PPP flux to generate NADPH and ribose that is consumed in the biosynthesis of macromolecules and ROS detoxification [74]. The gene discussed is G6PD; the disease is colorectal carcinoma.